Search - tctmd.com

Displaying 1 - 20 of 147

Sort: Relevancy | Date

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

L.A. McKeown

October 01, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

L.A. McKeown

July 10, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

L.A. McKeown

March 03, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

L.A. McKeown

December 23, 2024

News Daily News

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

L.A. McKeown

November 26, 2024

Advertisement

HF Care Differs Among Asian Subgroups in the US

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

Evolocumab Wins for Primary Prevention in VESALIUS-CV

Recognize and Enable Care for Post-MI Psychological Distress: AHA

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Healthcare Expenses Increase After GLP-1 Prescription

Heart Disease Treatment Costs $100 Billion per Year in the US

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

No Clear Risk of Dementia After TIA: Framingham Heart Study

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Cardiotoxicity Rare With Common GI Chemotherapy

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content